Smith & Nephew plc (LON:SN)

Market Cap	10.14B +5.0%
Revenue (ttm)	4.58B +6.1%
Net Income	464.38M +51.7%
EPS	0.53 +52.3%
Shares Out	849.89M
PE Ratio	22.43
Forward PE	14.19
Dividend	0.29 (2.47%)
Ex-Dividend Date	Mar 26, 2026

Volume	2,133,765
Average Volume	2,980,663
Open	1,199.50
Previous Close	1,195.50
Day's Range	1,189.50 - 1,207.50
52-Week Range	937.80 - 1,441.50
Beta	0.68
RSI	35.89
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 16,988
• Stock Exchange: London Stock Exchange
• Ticker Symbol: SN

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Financial numbers in USD